Singapore to become a “world class hub” for biomedical
sciences
|
Lim Hng Kiang: Singapore has attracted some major biotechnological companies
|
The congress was officially opened by Lim Hng Kiang,
Singapore’s minister for health and second minister for finance. Welcoming
participants to the congress, he told them that Singapore was developing
biomedical sciences as the fourth pillar of the country’s manufacturing
sector alongside the electronics, chemical and engineering sectors. “Our
intent is to develop Singapore into a world-class biomedical sciences
hub with capabilities across the whole value chain from basic and clinical
research to product and process development, full-scale manufacturing,
regional headquarters activities and health care delivery,” he said.
Singapore had been able to attract major pharmaceutical,
biotechnological, medical devices and health care services companies to
invest in it. With the country’s continuing investments in human capital
development and research and development capabilities, Mr Lim believed
that Singapore was well positioned to grow this industry further.
Back to Top
|
